In an unprecedented advancement in cancer treatment, a research team led by Professor Kwang-Hyun Cho from KAIST has developed a groundbreaking technology that targets colon cancer by transforming malignant cells into normal-like cells without killing them. Unlike traditional cancer therapies that
Multiple myeloma (MM), a complex form of blood cancer originating in plasma cells, relentlessly impairs blood counts and immune functions. Despite breakthroughs in treatment modalities, MM largely remains incurable, with patients often enduring cycles of remission interrupted by relapses. This
Mirror bacteria, theoretical organisms composed of chiral molecules that are mirror images of those found in natural life forms, have sparked significant debate within the scientific community. These organisms hinge on the concept of chirality, where "right-handed" amino acids and "left-handed"
Imagine a world where a simple leaf extract from an ancient tree could offer a safer and more effective treatment for pain and arthritis, potentially revolutionizing how we manage these chronic conditions. This scenario is not far-fetched, thanks to groundbreaking research on the medicinal
A significant breakthrough in the understanding of autism spectrum disorder (ASD) has recently emerged, shedding light on the genetic factors linked to this complex condition and its male predominance. Conducted by researchers from The Hospital for Sick Children (SickKids) in Canada and the
The human brain's ability to process sensory information is a marvel of biological engineering. Recent research from Harvard Medical School has uncovered new insights into how the brain processes touch and hearing simultaneously, revealing a complex interplay between these senses that enhances our
Recent research has delved into the cognitive limitations of large language models (LLMs), or "chatbots," when subjected to dementia screening tests traditionally used on humans. The study, published in the Christmas issue of The BMJ, reveals that almost all leading LLMs exhibit signs of mild
The recent announcement by Russia regarding the development of a groundbreaking mRNA cancer vaccine represents a significant milestone in the global fight against cancer. Scheduled for free distribution in early 2025, this innovative vaccine has captured worldwide attention due to its potential to
The trial of handheld translation devices in a network of eight GP surgeries in Southampton has demonstrated impressive results, paving the way for improved communication with 5,850 non-English-speaking patients. This innovative trial spanned several months, from April 2024 to August 2024, and was
MilliporeSigma, the Life Science business of Merck KGaA in the U.S. and Canada, has announced a definitive agreement to acquire HUB Organoids Holding B.V. (HUB). This acquisition marks a significant step forward in enhancing their 2D and 3D cell culture portfolio with the innovative technology of
